Formaldehyde

Formaldehyde

SCHEMBL2020497

C=O.CC(=O)Nc1cccc(Nc2ncnc3c2c(C(=O)c2ccccc2)cn3C)c1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.50
PIP4K2A P48426 2/20 0.47
PIK3CG P48736 1/20 0.46
MAPT P10636 7/20 0.46
POLB P06746 2/20 0.44
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
KDM4E B2RXH2 3/20 0.43
MAPK1 P28482 1/20 0.43
EGFR P00533 5/20 0.42
MAPK14 Q16539 1/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
HSD17B10 Q99714 1/20 0.41
BRAF P15056 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL27887401 1.00 ABCG2 (0.50) ABCG2PIP4K2APIK3CGMAPTPOLB
SCHEMBL2019872 0.98 ABCG2 (0.52) ABCG2PIP4K2APIK3CGMAPTPOLB
SCHEMBL2023831 0.86 ALDH1A1 (0.47) MAPTPOLBALDH1A1MEN1KMT2A
SCHEMBL2020499 0.85 NTRK1 (0.42) ABCG2MAPTPOLBALDH1A1MEN1
SCHEMBL2019802 0.78 ABCG2 (0.54) ABCG2EGFRBRAF
SCHEMBL1228737 0.77 DHODH (0.47) MAPTPOLBALDH1A1MEN1KMT2A
SCHEMBL1940103 0.73 PDGFRB (0.67) MEN1KMT2AEGFR
SCHEMBL1230153 0.71 HDAC1 (0.44) MAPTMAPK1
SCHEMBL2026264 0.71 POLB (0.47) POLBALDH1A1MEN1KMT2AMAPK1
SCHEMBL15381969 0.70 BTK (0.50) ABCG2PIP4K2AEGFRHSD17B10BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8580803-B2 Substituted pyrrolo-aminopyrimidine compounds ARQULE, INC. (US) 2013-11-12 US disclosed
EP-2519525-A2 SUBSTITUTED PYRROLO-AMINOPYRIMIDINE COMPOUNDS ArQule, Inc. (US) 2012-11-07 EP disclosed
WO-2011082273-A2 SUBSTITUTED PYRROLO-AMINOPYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2011-07-07 WO disclosed
US-20110160203-A1 Substituted Pyrrolo-Aminopyrimidine Compounds ARQULE, INC. (US) 2011-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160203-A1 Substituted Pyrrolo-Aminopyrimidine Compounds DPYD, TYMP, DHFR ABCG2 1489/4885PIP4K2A 1187/4885PIK3CG 504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.